Total Payments
$3,182
2024 Payments
$374.56
Companies
23
Transactions
213
Medicare Patients
4,441
Medicare Billing
$915,323
Payment Breakdown by Category
Food & Beverage$3,182 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,182 | 213 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,047 | 62 | $0 (2024) |
| Novo Nordisk Inc | $432.56 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $314.66 | 22 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $208.65 | 15 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $133.41 | 9 | $0 (2020) |
| PFIZER INC. | $114.33 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $103.80 | 7 | $0 (2023) |
| Lilly USA, LLC | $102.23 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $96.38 | 8 | $0 (2022) |
| ABBVIE INC. | $81.60 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.56 | 23 | AstraZeneca Pharmaceuticals LP ($214.46) |
| 2023 | $353.09 | 17 | AstraZeneca Pharmaceuticals LP ($196.86) |
| 2022 | $352.86 | 26 | Novo Nordisk Inc ($52.71) |
| 2021 | $416.47 | 30 | AstraZeneca Pharmaceuticals LP ($118.43) |
| 2020 | $209.12 | 16 | AstraZeneca Pharmaceuticals LP ($50.83) |
| 2019 | $521.14 | 37 | AstraZeneca Pharmaceuticals LP ($156.92) |
| 2018 | $465.82 | 34 | AstraZeneca Pharmaceuticals LP ($183.27) |
| 2017 | $488.89 | 30 | Novo Nordisk Inc ($111.71) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Obesity | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Obesity | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $48.50 | General |
| Category: Respiratory | ||||||
| 02/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Respiratory | ||||||
| 12/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 987 | 3,229 | $349,360 | $224,562 |
| 2022 | 22 | 1,375 | 4,216 | $459,220 | $286,667 |
| 2021 | 22 | 1,157 | 3,254 | $347,605 | $223,149 |
| 2020 | 16 | 922 | 2,594 | $281,400 | $180,944 |
Total Patients
4,441
Total Services
13,293
Medicare Billing
$915,323
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 211 | 1,083 | $119,450 | $88,700 | 74.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 185 | 648 | $64,800 | $39,794 | 61.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 114 | 124 | $24,800 | $18,506 | 74.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 255 | $31,875 | $18,499 | 58.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $13,600 | $9,670 | 71.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 149 | $14,900 | $7,784 | 52.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 161 | $16,100 | $7,483 | 46.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 19 | 161 | $12,075 | $6,933 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 72 | $10,800 | $6,266 | 58.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 122 | $9,135 | $4,979 | 54.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 19 | 120 | $7,800 | $4,146 | 53.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 28 | 34 | $5,950 | $3,896 | 65.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 14 | $4,200 | $3,058 | 72.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 33 | $6,600 | $1,529 | 23.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 11 | 11 | $2,200 | $1,231 | 55.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 70 | $2,450 | $844.20 | 34.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 12 | 13 | $1,040 | $442.12 | 42.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $455.00 | $441.61 | 97.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $455.00 | $284.70 | 62.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 22 | 65 | $675.00 | $77.83 | 11.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 281 | 1,194 | $131,560 | $92,162 | 70.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 279 | 1,057 | $105,700 | $62,874 | 59.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 247 | 280 | $56,000 | $39,313 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 243 | $30,375 | $17,820 | 58.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 44 | 223 | $22,250 | $12,019 | 54.0% |
About Dr. Deepa Patel, M.D
Dr. Deepa Patel, M.D is a Internal Medicine healthcare provider based in Spotswood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134225162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepa Patel, M.D has received a total of $3,182 in payments from pharmaceutical and medical device companies, with $374.56 received in 2024. These payments were reported across 213 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,182).
As a Medicare-enrolled provider, Patel has provided services to 4,441 Medicare beneficiaries, totaling 13,293 services with total Medicare billing of $915,323. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Spotswood, NJ
- Active Since 09/16/2006
- Last Updated 08/04/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134225162
Products in Payments
- FARXIGA (Drug) $727.26
- XARELTO (Drug) $277.72
- ENTRESTO (Drug) $179.59
- JARDIANCE (Drug) $149.61
- LOKELMA (Drug) $142.06
- Ozempic (Drug) $139.43
- AIRSUPRA (Drug) $136.79
- Victoza (Drug) $114.64
- TOUJEO (Drug) $87.70
- Rybelsus (Drug) $78.33
- Kerendia (Drug) $58.12
- MYRBETRIQ (Drug) $54.92
- ELIQUIS (Drug) $45.76
- CHANTIX (Drug) $43.09
- QULIPTA (Drug) $42.58
- Vascepa (Drug) $42.41
- JANUVIA (Drug) $39.27
- INVOKANA (Drug) $36.94
- TRULICITY (Drug) $36.66
- UBRELVY (Drug) $36.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.